Key Responsibilities
- Develop and execute a comprehensive investor relations strategy aligned with the company's corporate objectives, pipeline milestones, and long-term growth ambitions
- Manage the company’s current investor relations agency and future public relations/media agency
- Serve as a day-to-day point of contact for the buy-side and sell-side investment community, fielding inquiries and building relationships with current and prospective shareholders
- Partner with agencies to manage the production of investor-facing materials, including all press releases, earnings call scripts and Q&A prep, investor presentations, media communications, fact sheets, and the annual report
- Partner with executive team to prepare for and manage quarterly earnings calls, board meetings, investor conferences, medical conferences, non-deal roadshows and R&D-day presentations
- Lead proactive and targeted investor outreach, including identifying and cultivating relationships with new institutional investors
- Monitor and analyze sell-side analyst research, market activity, shareholder composition, and peer/competitor developments; deliver regular updates and insights to executive team and the Board
- Collaborate cross-functionally with R&D, clinical development, regulatory, legal, and corporate communications to ensure accurate, consistent, and compliant messaging across all investor touchpoints
- Support corporate development activities, including materials related to M&A, partnerships, licensing deals, and capital markets transactions (e.g., follow-on offerings)
- Manage corporate website including investor relations section
- Ensure compliance with SEC regulations, Regulation FD, and other disclosure requirements in coordination with Legal
- Help build out and scale the IR function's tools, processes, and infrastructure as the company grows
- Attend and help document minutes and key decisions at weekly Executive Committee (EC) meetings. Follow up on key decisions and action items to make sure they are being implemented. Work with the CEO and EC on corporate communications and special projects
- Through close partnership with Program Management Team assist Executive Team with coordinating activities requiring cross-functional involvement
Basic Qualifications
- Bachelor's degree required; MBA, CFA, or advanced scientific degree a plus
8+ years of relevant experience in investor relations, equity research, investment banking, or corporate finance, with a meaningful portion of that experience in biotech, pharma, or life sciences - Experience at a publicly traded biotech/pharmaceutical company strongly preferred; direct experience supporting earnings calls, roadshows, and SEC reporting cycles
- Strong understanding of financial reporting, valuation methodologies, and capital markets used by investment professionals
- Exceptional written and verbal communication skills, highly organized with meticulous attention to detail and accuracy
- Strategic thinker who can manage multiple priorities in a fast-paced, dynamic environment and deliver polished output under tight deadlines
Preferred Qualifications
- Scientific fluency — comfort engaging with clinical and regulatory content, with the ability to translate complex science into an accessible investment narrative, especially in autoimmune diseases
- Experience with IR-specific tools (e.g., shareholder ID/CRM platforms, earnings call/webcast providers) a plus
- Proven track record building relationships and influencing across all levels of an organization, including senior executives and the Board
- Experience in a Chief-of-Staff or senior project management type of role
- Integrity: We put patients first, uphold the highest ethical standards, and communicate with honesty and transparency
- Learning & Growth: We ask questions, challenge the status quo, seek and provide constructive feedback, and invest in the development of ourselves and others
- Drive for Excellence: We set ambitious goals, take ownership, honor our commitments, move with urgency, and deliver rigorous, high-quality, and data-driven work
- Innovation: We pursue transformative science, think creatively, and do more with less through resourcefulness and continuous improvement
- Teamwork & Collaboration: We communicate openly, debate constructively, mentor and learn from one another, and recognize that our strongest results come from working together
Attovia™ is a clinical-stage biopharmaceutical company developing next-generation biotherapeutics for immune-mediated diseases with high unmet need. Our product candidates are internally discovered using our proprietary ATTOBODY™ platform, an evolution-driven, high-throughput biologics platform that enables the rapid discovery and creation of diverse biparatopic complex biologics. Our pipeline spans chronic pruritic diseases, inflammatory skin diseases, inflammatory bowel disease, and other immune-mediated conditions.
We take pride in fostering a strong team and dynamic work environment, and we are seeking individuals who align with our values and contribute to a positive and impactful workplace.
Attovia is located in San Carlos, CA.
Attovia is an equal opportunity employer. We consider all qualified applicants for employment without regard to race, color, ancestry, national origin, religion or creed, age, sex, pregnancy, childbirth, breastfeeding or related medical conditions, sexual orientation, gender, gender identity or gender expression, marital status, medical condition, genetic information, physical or mental disability, military or veteran status, reproductive health decision-making, or any other characteristic protected by applicable federal, state, or local law.
Learn more about Attovia: www.attovia.com
Notice to Employment Agencies
The Attovia talent acquisition program is managed through internal resources, and unsolicited referrals and resumes are not accepted from employment agencies, unless advance written authorization is granted from the Human Resources department. Attovia shall not be liable for any fees arising from any unsolicited or unauthorized candidate information received relative to position vacancies.
Skills Required
- Bachelor's degree
- 8+ years of relevant experience in investor relations, equity research, investment banking, or corporate finance
- Meaningful experience in biotech, pharmaceutical, or life sciences
- Experience at a publicly traded biotech or pharmaceutical company
- Experience supporting earnings calls, roadshows, and SEC reporting cycles
- Strong understanding of financial reporting, valuation methodologies, and capital markets
- Exceptional written and verbal communication skills
- Strong organization, attention to detail, and accuracy
- Ability to manage multiple priorities in a fast-paced environment and deliver polished work under tight deadlines
- Scientific fluency and ability to translate clinical and regulatory content into an investment narrative
- Experience with investor relations tools, shareholder identification or CRM platforms, and earnings call or webcast providers
- Track record of building relationships and influencing senior executives and boards
- Chief of Staff or senior project management experience
- MBA, CFA, or advanced scientific degree
What We Do
Attovia is creating a pipeline of biotherapeutics for the treatment of immune-mediated diseases. We leverage ATTOBODY™, our proprietary biologics platform, to generate potentially first-in-class and best-in-class multi-specifics. ATTOBODIES utilize spatial positioning technology to achieve biparatopic target engagement. The biparatopic binding mode of ATTOBODIES results in ultra-high affinity, which translates to best-in-class potency in biologic activity. ATTOBODIES offer unconstrained engineering, making them an ideal modality for the development of multi-specific biologics, with tunable half-life translating to the potential for quarterly or less frequent dosing in patients. The high-throughput, evolution-based ATTOBODY discovery platform delivers a high degree of diversity at industry-leading speed, accelerating and de-risking therapeutics development, offering the potential to become the next-generation modality of choice. Learn more at www.attovia.com.








